Article Text

Download PDFPDF

3PC-037 Liquid chromatography mass spectrometry analysis of doxorubicin and epirubicin after freezing
  1. V Garau1,
  2. M Crobeddu2,
  3. GA Carrucciu1,
  4. P Serra1,
  5. P Caboni2
  1. 1A Businco’ Oncology Hospital, Hospital Pharmacy, Cagliari, Italy
  2. 2University of Cagliari, Pharmacy, Cagliari, Italy


Background and Importance The chemical-physical stability, reported among the technical characteristics of the drugs, indicates the parameters to be respected for the safety use of the preparations but often the conditions of storage of the drugs can undergo significant variations. The stability data reported by the manufacturers are often limited while in clinical practice it is necessary to extend the conditions of use and the validity times of the preparations. In reality, it may happen that drugs are transported, stored and used in temperature conditions other than those indicated by the manufacturer without, however, having sufficient data on safety and stability for use outside the certified conditions.

Aim and Objectives The objective of the analysis performed is to evaluate the chemical and physical stability of doxorubicin and epirubicin after being stored in the freezer.

Material and Methods The formulations of doxorubicin and epirubicin stored in the freezer for a period of time exceeding 48h were analysed. The drug solutions were thawed at room temperature and stored in the refrigerator until the time of the chemical-physical analysis. For analysis 10 microliters were subsequently diluted from each vial and injected into LC QTOF MS(n=4).

Results Data obtained from the analysis carried out with a mass chromatographic technique highlighted the chemical and physical stability of the drugs analysed. The measured concentration of doxorubicin for the overrange sample was 1.995 ± 0.005 mg/ml while for the external doxorubicin standard was 1.996 ± 0.008 mg/ml. Some trend was observed for epirubicin, 2.009 ± 0.007 mg/ml versus 2.005 ± 0.005 mg/ml for the overrange sample.

Conclusion and Relevance The analysis showed the chemical-physical stability of the compounds studied allowing their use even outside the storage conditions indicated in the technical data sheet. The results showed that there were no statistically significant differences in the concentration of over range doxorubicin and epirubicin samples even after accidental freezing. This consists in a reduction of drug waste in real conditions. An easy access to mass spectrometry analytical platform may allow the evaluation of drug stability, redefining the chemical-physical stability with certified data.

Conflict of Interest No conflict of interest

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.